Fingerprint
Dive into the research topics of 'Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: Safety, clinical activity, pharmacodynamics, and immunologic correlates'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically